Invention Grant
![Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine](/docs/US/2013-05-21/US08445494B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
-
Application No.: US12995771Application Date: 2009-06-04
-
Publication No.: US08445494B2Publication Date: 2013-05-21
- Inventor: Jun Qiu , Qi Gao , Shuang Liu , Matthew Isherwood
- Applicant: Jun Qiu , Qi Gao , Shuang Liu , Matthew Isherwood
- Applicant Address: US NJ Princeton US NY Albany
- Assignee: Bristol-Myers Squibb Company,Albany Molecular Research, Inc.
- Current Assignee: Bristol-Myers Squibb Company,Albany Molecular Research, Inc.
- Current Assignee Address: US NJ Princeton US NY Albany
- Agent Warren K. Volles
- International Application: PCT/US2009/046256 WO 20090604
- International Announcement: WO2009/149258 WO 20091210
- Main IPC: A61K31/501
- IPC: A61K31/501 ; C07D401/04 ; A61P25/24
![Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine](/abs-image/US/2013/05/21/US08445494B2/abs.jpg.150x150.jpg)
Abstract:
The present disclosure generally relates to a crystalline form of 6-[(4S)-2-methyl-4-(naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine. The present disclosure also generally relates to pharmaceutical compositions comprising the crystalline form, as well of methods of using a crystalline form in the treatment of depression and other conditions and methods for obtaining such crystalline form.
Public/Granted literature
- US20110160220A1 CRYSTALLINE FORM OF 6-[(4S)-2-METHYL-4-(2-NAPHTHYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL]PYRIDAZIN-3-AMINE Public/Granted day:2011-06-30
Information query
IPC分类:
